oral administration of sofalcone at doses of 200 and 400 mg/kg significantly inhibited the pg metabolizing enzyme , 15-hydroxy-pg-dehydrogenase ( 15-oh-pg-dh ) activity and increased pge2 contents in the rat gastric mucosa .
C0033554
pg
C0012472
pge2